A mouse immunoglobulin G1 monoclonal antibody (mAb), MRC OX-62 (OX-62), was raised against density gradient-enriched rat veiled (dendritic) cells obtained from lymph. In suspensions of lymphoid cells, the OX-62 mAb only labeled cells with the characteristics of veiled cells. The OX-62 mAb was used with a magnetic cell sorter to enrich or deplete veiled cells, and the enriched veiled cells were potent stimulators in the primary allogeneic mixed leukocyte reaction. Immunohistochemical staining of tissue sections showed that the OX-62 mAb did not label all classical dendritic cells and was not restricted to this cell type. In lymphoid tissues, the labeling correlated with dendritic cells, but in skin, major histocompatibility complex class II + cells were OX-62-, while another CD3 + cell with dendritic morphology was strongly OX-62 + . It seems that the OX-62 mAb may be restricted to dendritic cells and probably to T/$ T cells. The OX-62 mAb will be of use in delineating minor subsets of cells with dendritic morphdogy in various tissues. Sodium dodecyl sulfate-polyacrylamide gel dectrophoresis analysis of veiled ceil-enriched populations immunoprecipitated with the OX-62 mAb gave bands with the biochemical characteristics of an integrin. The OX-62 mAb recognized the c~-like subunit.
D
endritic cells are classified as a heterogeneous group of cells with dendritic morphology found in lymphoid and nonlymphoid tissues, and as veiled cells in lymph (1) . Dendritic cells originate from bone marrow but the lineage is unresolved (2) . Attention focused on dendritic cells after the isolation of the spleen dendritic cell and the observation that these cells are the most potent accessory cells identified at inducing primary T cell responses in vitro (3) . The immunoregnlatory role of dendritic ceils in vivo is implicated by their presence in the T-dependent areas of secondary lymphoid organs (4, 5) . Identification of dendritic ceils is based on properties of the isolated spleen dendritic cell, which indude dendritic morphology (6) , constitutive expression of MHC class II (7), low phagocytic ability in vitro (8) , and potent accessory function in the primary allogeneic MLR (3) . The need for mAbs that are specific for dendritic calls is evident (9) , but few useful mAbs are available (10) (11) (12) (13) (14) (15) (16) (17) , and anti-MHC class II mAbs are of limited value. One major problem in generating dendritic cell mAbs is that it is difficult to obtain large numbers of dendritic cells for immunization and there are no call lines equivalent to normal dendritic cells (18) (19) (20) . In this paper the production of a mouse IgG1 mAb (OX-62) useful for the purification of rat veiled ceils and recognizing an antigen with the biochemical properties of an integrin is described.
Materials and Methods
Animals. BALB/c (H-2 d) and DBA/2 (H-2 d) inbred mice were obtained from the Sir William Dunn School of Pathology (Oxford). F1 hybrids between these two strains were bred at the MRC Cellular Immunology Unit (Oxford). PVG (RT1 ~ and AO (R.T1 u) specific pathogen-free inbred rats were obtained from the MRC Cellular Immunology Unit. Rats were used at 8-12 wk, except where stated otherwise.
Mesenteric Lp~phadenectom? Cecal, mesenteric, postgastric, and portal lymph nodes were surgically removed using blunt dissection from 90-g male PVG rats. Mesenteric lymphadenectomized rats were allowed to recover for a minimum of 6 wk before thoracic duct cannulation.
Cell Populations. Cell suspensions were prepared in PBS containing 0.25% BSA. Thoracic duct leukocytes (TDL) j were obtained by thoracic duct cannulation of normal and mesenteric lymphadenectomized rats (21) . Cells were collected overnight in ice-cold glucose saline (22) containing 20 U/ml heparin. Density gradient-enriched veiled cells were prepared from TDL obtained from mesenteric lymphadenectomized rats (MLNX TDL) by centrifugation over Nycoprep TM 1.068 (Nycomed, Oslo, Norway). Thymocytes, splenocytes, and lymph node cells were obtained by removing appropriate organs and teasing into single call suspen-1 Abbreviations used in this paper: MLNX TDL, thoracic duct leukocytes obtained from mesenteric lymphadenectomized rats; RAM, rabbit antimouse; TDL. thoracic duct leukocytes.
sions. PBL were prepared from blood obtained by cardiac puncture and separated over Isopaque-Ficoll. Bone marrow cells were obtained by flushing the marrow cavity of the femur with PBS. Resident peritoneal exudate cells were obtained from the peritoneal cavity of freshly killed rats. Elicited peritoneal exudate cells were obtained from the peritoneal cavity 4 d after intraperitoneal injection of 10 ml of thioglycollate broth. Con A blasts were obtained after a 3-d culture of lymph node cells at 106/ml in RPMI 1640 supplemented with 5% heat-inactivated FCS, 2 mM glutamine, 1 mM sodium pyrnvate, 2.5 x 10 -s M 2-ME, and antibiotics (supplemented RPMI), and 5/~g/ml Con A. Con A blasts were separated over Isopaque-Picoll and washed in oe-methyl-D-mannoside (20 mg/ml). LPS blasts were obtained after a 2-d culture of lymph node cells at 106/ml in supplemented RPMI and 10/~g/ml LPS.
rnAbs and Antibody Conjugates. The OX-62 hybridoma was produced by immunizing a BALB/c mouse with rat PVG density gradient-enriched veiled cells obtained from the cannulated thoracic duct of mesenteric lymphadenectomized rats. The immunization procedure was a combination of three intravenous and intraperitoneal injections with 5-10 x 106 cells at monthly intervals. 5 d after the last injection, the splenocytes were fused with NSO myeloma cells according to the method of Galfr~ and Milstein (23) . After growth of the hybrid cell lines, supernatants were screened for specificity by immunohistochemistry (see below). Selected hybridomas were cloned twice by limiting dilution. Ascites fluid was prepared in (BALB/c x DBA/2)Ft mice pretreated with pristane. The subdass of the OX-62 mAb was determined using an anti-mouse monoclonal isotyping kit (Serotec, Kidlington, Oxon, England).
Other mAbs used were SN3 (mouse anti-squid Sgp 1) (24), OX-6 (mouse anti-rat MHC class II, IgG1) (25), OX-8 (mouse anti-rat CDS, IgG1) (26), OX-12 (mouse anti-rat IgG ~ chain, IgG2a) (27) , OX-17 (mouse anti-rat MHC class II, IgG1) (28), OX-21 (mouse anti-human C3b inactivator, IgG1) (29) , and OX-42 (mouse anti-rat CD18/CD11b, IgG2a) (30) . mAbs were used as tissue culture supernatants, purified IgG from ascites fluid (31) , and purified IgG from ascites fluid conjugated with biotin (32) .
Other antibodies used were rabbit anti-mouse IgG mAb conjugated with peroxidase (RAM-peroxidase) (Dako, High Wycombe, Bucks, England), affinity-purified rabbit F(ab')2 anti-mouse IgG mAb (Serotec) conjugated with fluorescein (KAM-FITC) (32), biotin (RAM-biotin) (32) , and iodine (mI-KAM) (33) , and fluorescein-conjugated goat anti-mouse IgG1 (GAM-FITC) (Southern Biotechnology Associates, Inc., Birmingham, AL).
Flow Cytofluorography. Labeling of cells for analysis on a
FACScan | (Becton Dickinson & Co., Mountain View, CA) was performed as described previously (32) . Cells were gated on the scatter profiles to exclude dead cells and erythrocytes.
Magnetic Cell Sorting. The principle of the magnetic cell sorting system and conditions for labeling and sorting cells have been described in detail (34, 35) . All incubations, washes, and sorting were carried out at 4~ in PBS containing 5 mM EDTA and 10 mM NAN3. Briefly, 109 cells were labeled in 5-ml mAb tissue culture supernatant for 30 rain, washed, labeled in 1 ml RAM-biotin (10 /~g/rul) for 30 rain, washed, labeled in 1 ml avidin-FITC (25/~g/ml) (Becton Dickinson & Co., Cowley, Oxford, England) for 30 min, washed, and finally incubated in 1 ml containing 10 #1 biotinylated superparamagnetic microbeads (Becton Dickinson & Co.) for 5 rain. Labeled cells were added to the appropriately sized column in the magnetic fidd. Unlabeled cells were collected in the first 10-15-ml volume. The column was washed to remove unlabeled, weakly bound, and dead cells. Magnetically labeled cells were duted from the column outside the magnetic field. In some experiments enriched and depleted Populations were further depleted of contaminating cells by a second magnetic sort. The etficiency of depletion and enrichment was determined by flow cytofluorography using a FACScan | MLR. 5 Preparation of Specimens for Imraunohistochemistty. For cryostat sections, organs were removed from rats, embedded in OCT (Miles, Elkhart, IN), and frozen in 2-methylbutane cooled in liquid nitrogen. 5-/ira cryostat sections were cut onto four-spot glass slides (C. A. Hendley, Essex, England), air dried, and stored desiccated at -70~ For epidermal ear sheets, rat ears were split longitudinally and incubated in 116 mM NaCI, 2.6 mM KC1, 8 mM Na2HPO4, 1.4 mM KH2PO4, and 20 mM EDTA, pH 7.3, for 2 h at 37~ on a rotator (36) . Epidermal sheets were separated using watchmaker's forceps under a dissecting microscope. For isolated cells, cytospin preparations were made using a cytocentrifuge, air dried, and stored desiccated at -70"C.
Immunohistocheraistry. The peroxidase method was used for staining sections as described previously (37) . All incubations were carried out at 4"C. Briefly, cryostat sections, epidermal sheets, and cytospin preparations were fixed in ethanol for 10 min, washed, incubated with mAb tissue culture supernatant for 60 min, except for epidermal ear sheets, which were incubated overnight, washed, incubated with RAM-peroxidase (25 /zg/ml) for 60 min, and washed. Peroxidase was visualized using 3,3'-diaminobenzidine tetrahydrochloride. Staining was enhanced using 0.01 M imidazole in the 3,Y-diaminobenzidine tetrahydrochloride solution. Slides were lightly counterstained with Harris' haematoxylin, dehydrated, and mounted in DePeX (BDH Ltd., Pooh, England). Immunofluorescence was used for double labeling of epidermal ear sheets. Fixed tissues were incubated with the first mAb tissue culture supematant overnight, washed, and incubated with GAM-FITC (15/zg/ml) for 90 min. After washing, tissues were incubated with 30% mouse serum for 60 min, incubated with the second biotinylated IgG mAb (10/~g/ml) for 4 h, washed, incubated with Texas red-conjugated streptavidin (10/~g/ml) (Southern Biotechnology Associates, Inc.) for 90 rain, washed, and mounted in Citifluor glycerol solution (Citifluor Ltd., London, England).
Cell Surface Radioiodination and Imraunoprecipitaa'on. 107 density gradient-enriched veiled cells were surface labeled by an H202 lactoperoxidase-catalyzed radioiodination method (38) . Labeled cells were solubilized in 500 ~1 lysis buffer comprising 10 mM Tris-HCL, pH 7.5-8, 150 mM NaC1, 5 mM EDTA, 1% NP-40, 1 mM PMSF, and 5 mM iodoacetamide for 30 rain at 4~ Samples (2.5 x 106 cell equivalents) were centrifuged and the supernatants precleared for 30 rain at 4oC on a rotating wheel with 100/zl of a 10% suspension of Sepharose CL-4B beads (Pharmacia, Uppsala, Sweden), which had been covalently coupled to purified mAb IgG using cyanogen bromide ("~ 10 mg purified mAb IgG/ml CL,4B beads) (39) . Predearing was repeated three times. Precleared samples were directly immunoprecipitated for 1 h at 4~ on a rotating wheel with 30/~1 of a 10% solution of Sepharose CL4B beads covalently coupled to purified mAb IgG. Immunopredpitated samples were washed in the following buffers: (a) 10 mM Tris-HCl, pH 8.0, containing 500 mM NaC1, 0.5% NP-40, and 0.05% SDS; (b) 10 mM Tris-HCl, pH 8.0, containing 150 mM NaCI, 0.5% NP-40, 0.5% sodium deoxycholate, and 0.05% SDS; (c) 10 mM Tris-HCl, pH 8.0, containing 0.05% SDS. Samples and molecular weight markers (Rainbow TM protein molecular weight markers; Amersham, Bucks, England) were boiled in 15 #1 sample buffer for 5 min and run on 7.5% SDS-PAGE using a mini-gel apparatus (Bio-Kad Laboratories, Richmond, CA) (40) . Gels were fixed, dried, and exposed to Hyperfilm TM (Amersham) at -70~
Western Blotting. Veiled cell-enriched lysates prepared as described for immunoprecipitation were run on 7.5% SDS-PAGE using a mini-gel apparatus (Bio-Rad Laboratories). Protein was transferred to nitrocdlulose (HybondZM-C-extra; Amersham) using a mini trans-blot dectrophoretic transfer apparatus (Bio-gad Laboratories). Membranes were placed in PBS containing 5% dried nonfat milk powder for 24 h at 4~ Ascites fluid containing the appropriate mAb was added to give a final concentration of 1-50 #g/ml, and the membranes were incubated for 2 h at 4~ with rocking. The membranes were washed three times in PBS/0.05% Tween 20 before addition of nSI-KAM (sp act '~1.5 #Ci/#g IgG at a dilution of 1@ cpm/ml) in PBS/0.05% Tween 20/1% BSA. After incubation for 1 h at 4~ the membranes were washed three times in PBS/0.05% Tween 20 and exposed to Hyperfilm TM at -70~
Results and Discussion
Production of the 0X-62 mA~ Out of a total of four fusions and screening ,,o2,000 wells, one hybridoma secreting a mouse anti-rat IgG1 mAb (OX-62) was sdected on the basis of immunohistochemical staining of cells with dendritic cell morphology in tissue sections of lymphoid organs. In the current studies, <10% of the mAbs produced were against MHC class II antigens, although anti-MHC class II mAbs have been reported to comprise up to 50% of positive hybridomas in anti-dendritic call fusions (16) . A number of interesting mAbs against endothelial determinants were produced.
Expression of the 0X-62 Antigen by Different Leukocyte
T~es. Fig. 1 shows FACScan | profiles of different isolated leukocyte types labeled with the OX-62 mAb. Positive profiles were only obtained with density gradient-enriched veiled cells from MLNX TDL (Fig. 1 C) . Immunohistochemical staining of cytospin preparations of MLNX TDL and TDL confirmed that veiled ceils were the only cell type labded (Fig. 3, I and J). Thymocytes (Fig. 1 F), splenocytes (Fig. 1 G) , and lymph node calls ( Fig. 1/4) , tissues known to have OX-62 + cells in low numbers by immunohistochemical staining of sections (Fig. 3, A, C , and E), gave staining with the OX-62 mAb at a level barely distinguishable from background on the FACScan | indicating that the OX-62 + ceils are normaUy present at too low a frequency to be dearly detectable by this method. Resident peritoneal exudate ceils (Fig. 1/) , thioglycollate didted peritoneal exudate cells ( Fig. 1.] ), LPS blasts ( Fig.  1 K) , and Con A blasts (Fig. 1 L) , were OX-62-. The OX-62 mAb failed to labd PBL and bone marrow cells when analyzed on a FACScan | (Fig. 1, D and E) and by immunohistochemical staining of cytospin preparations (data not shown).
Enrichment of Dendritic Cells. The infrequent distribution of dendritic cells makes isolation difficult. Dendritic cells can either be obtained in suspension in lymph or from lymphoid organs with or without enzyme digestion and adherence. Dendritic cells represent ,,,1% or less of these populations; therefore, further enrichment is dependent either on positive or negative sdection using relevant mAbs and/or nonspecific separation using density gradients (41, 42) .
The ability of the OX-62 mAb to enrich and deplete OX-62-labeled cells was assessed after magnetic sorting phenotypically by flow cytofluorography using a FACScan | morphologically, and functionally using magnetically sorted ceils 
Effect of the 0X-62 mAb on the Primary Allogeneic MLR.
OX-62 IgG added at the start of culture in a concentration range from 1.25 ng/ml to 2.5 #g/m1 had no effect on the MLR between CD4 responders from AO rats (i.e., OX-6, OX-17, OX-8, and OX-12 mAb-labeled and magnetically depleted TDL) and unseparated MLNX TDL stimulators from PVG rats (data not shown), indicating that the OX-62 antigen is not essential for T cell activation.
Distribution o.f the 0X-62 Antigen in Lymphoid Organs.
The distribution of the OX-62 antigen in lymphoid organs (Fig.  3 ) mostly coincided with previous reports of dendritic cell distribution based on microscopic and immunohistochemical studies (4, 6, 11, (13) (14) (15) (16) (43) (44) (45) (46) (47) . All cells labeled with the OX-62 mAb had a dendritic cell morphology. In the thymus, 0X-62 + cells were present in the medulla forming a diffuse network, which was concentrated at the corticomedullary junction (Fig. 3 A) . OX-62 + cells were also present in the lobular septa with occasional ceils present in the cortex (Fig. 3 A) , correlating with the large scattered ceils observed in the cortex in bone marrow chimeras (43) . In the spleen, OX-62 + cells were concentrated in the Tdependent areas, particularly around the region of the central arteriole but also throughout the red pulp (Pig. 3 C). The OX-62 + cells in the red pulp were rounded and more strongly stained compared with cells in the T-dependent areas where the borders were difficult to define. OX-62 + cells were present in the marginal zones and the peripheral white pulp infrequently (Fig. 3 C) . In the cervical lymph node, OX-62 + cells were present in the subcapsular sinus, Tdependent areas of the cortex, and in the medulla, but were rare in the follicles (Fig. 3 E) . In the Peyer's patch, OX-62 + cells were present in the interfollicular areas and in the epithdial dome regions, but were rare in the follicles (Fig. 3  C) . Background staining with an isotype-matched mAb OX-21 was negligible (Fig. 3 , B, D, F, and H). No difference in OX-62 staining was found between FVG, AO, DA, and Lewis rat strains, and OX-62 + cells were present in congenitally athymic PVG nude rats (PVG rnu/rnu) (data not shown), confirming previous results using anti-MHC class II mAbs (48) .
Distribution of the 0X-62 Antigen in Nonlymphoid Organs.
OX-62 + cells with dendritic morphology that coincided with known MHC class II dendritic cell distribution (48, 49) were present in the lamina propria of the small intestine (Fig. 4, A and B) , interstitium of the lung, portal triads of the liver, glomeruli of the kidney, islets of Langerhans of the pancreas, and epithelium of the choroid plexus (data not shown). Lack of OX-62 + cells in heart and skeletal musde (data not shown) contrasts with previous studies using anti-MHC dass II mAbs (48) (49) (50) . Unexpectedly, the OX-62 mAb revealed populations of OX-62 + MHC class II-ceils in the epithelium of the small intestine and in the epidermis of the skin. In the epithelium of the small intestine, only granular MHC class II staining has been reported (Fig. 4 B; and 47 ), but this staining was not associated with the OX-62 + intraepithelial cells (Fig. 4  A) . In epidermal sheets, OX-62 mAb labeling primarily revealed cells with a marked dendritic morphology comprising the cell body and nonoverlapping dendritic processes (Fig.  4 C) in contrast to OX-6 mAb labeling, which primarily revealed cells with less prominent dendrites (Pig. 4 D). Double immunofluorescence showed that most if not all the OX-62 + and MHC class II + populations were nonoverlapping (Fig. 4, E, F, and G) . The OX-62 + MHC class II-cells in the small intestine and the skin were CD3 + (data not shown) and probably represent 3//~ T cells (51) (52) (53) . Overall, the results indicate that the OX-62 mAb may label some but not all dendritic cells and probably "y/~ T cells. Furthermore, the identification of nonoverlapping OX-62 + MHC class II-and OX-62-MHC class II + populations in the skin with a similar distribution raises the question as to which cells migrate into the afferent lymphatics giving rise to the OX-62 + MHC class II + veiled ceils. Previous work has in- Fig. 5 A, lane 3) . The 150-kD band was the only band detected by the OX-62 mAb on Western blots (Fig. 5 B, lane  1) . The biochemical properties of the OX-62 antigen are characteristic of an integrin. Integrins consist of noncovalently associated cx (120-210-kD) and/3 (95-220-kD) subunits (64) . The strong 150-kD band present under nonredudng and reducing conditions is r subunit like and the weaker 120-kD band, which migrated faster under nonreducing conditions due to internal disulphide bonding (64) , is/5 subunit like. The stronger 150-kD band would be predicted as the OX-62 mAb recognizes the 150-kD band, and the noncovalent association of or//5 integrin subunits, which is weak under immunoprecipitation conditions, results in some coprecipitation of cx with/3 (65) and/3 with r (66). The/5 subunit is not/31, based on preclearing experiments with a crossreactive antipeptide antibody (65) foUowed by immunoprecipitation (data not shown), and not/32, based on preclearing experiments with the OX-42 mAb (CD18/CDllb) followed by immunopredpitation (data not shown). /31,/32, and/37 (/5p) are present in lymphoid cells (64) . The c~ subunit is not cx 3, cr s, or c~ 6, based on preclearing experiments with cross-reactive antipeptide antibodies (66) foUowed by immunoprecipitation (data not shown). The o~ subunits are grouped into those that have I domains and those that undergo posttranslational cleavage (~, r s, and c~ 6) to give a cytoplasmic/transmembrane/extracellular fragment (25 kD) (130-150 kD) (64) . The two <30-kD bands (Fig. 5 A, lanes I and 2) may represent alternative splicing of the cytoplasmic tail similar to that described for c~ 3 and ot 6 (67) . The presence of cleaved fragments under nonreducing (Fig. 5 A, lane I) and reducing (lane 2) conditions is not identical to previously described cleaved cz subunits, which are disulphide bonded (64) , with the exception of o~M29~ (68, 69) . The M290 mAb, which identifies/37 as deduced from sequence homology (70, 71) associated with a novel ot subunit, shows similar biochemical characteristics to the OX-62 antigen. It has been proposed that M290 (68-71), HML-1 (72, 73) , bet-ACT8 (74), and RGL-1 (75), which labds rat veiled cells (data not shown), recognize an homologous antigen present on intraepithelial lymphocytes.
Concluding Statement. OX-62 mAb seems to be restricted to dendritic cells in lymphoid and nonlymphoid organs, and to CD3 + cells with dendritic morphology, which are probably 3'//J T cells. The OX-62 antigen has the biochemical properties of an integrin. The mAb will be useful for cell purification, delineating lineage relationships among cells with dendritic morphology, and for molecular studies.
